Trafalgar International GCAN
OTC GCAN
$0.35 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Trafalgar International (GCAN) Common Equity (2016 - 2026)

Trafalgar International (GCAN) posted Common Equity of -$775025.0 for Q1 2026, down 100.04% on a QoQ basis from $2.0 billion in Q4 2025, and up 5.94% year-over-year from -$731557.7 in Q1 2025.

Analysis

Trafalgar International (GCAN) Common Equity (2016 - 2026) Analysis & Trends

Trafalgar International has reported Common Equity for 11 years, with the latest figure at -$775025.0 in Q1 2026.

  • On a quarterly basis, Common Equity rose 5.94% year-over-year to -$775025.0 in Q1 2026; TTM through Mar 2026 was -$775025.0, a 5.94% increase from a year earlier, with the FY2025 full-year figure at $2.0 billion, up 238117.88% from the prior year.
  • Common Equity was -$775025.0 for Q1 2026 at Trafalgar International, down from $2.0 billion in the prior quarter.
  • The five-year high for Common Equity was $2.0 billion in Q4 2025, with the low at -$1.1 million in Q3 2025.
  • Average Common Equity over 5 years is $117.0 million, with a median of -$661232.0 recorded in 2023.
  • The sharpest annual moves came in 2022 and 2025: Common Equity plunged 642.21% in 2022, then surged 238117.88% in 2025.
  • Over 5 years, Common Equity stood at -$544830.0 in 2022, then decreased by 21.36% to -$661232.0 in 2023, then fell by 27.08% to -$840273.0 in 2024, then soared by 238117.88% to $2.0 billion in 2025, then slumped by 100.04% to -$775025.0 in 2026.
  • The last three Common Equity figures came in at -$775025.0 (Q1 2026), $2.0 billion (Q4 2025), and -$1.1 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 84.97 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn -5.94 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 106.07 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn 41.95 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 85.49 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 80.86 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn - 2.61 Bn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 6.34 Bn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 6.40 Bn
10 Trafalgar International 217,335.05 217,335.05 - -775,025.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -775,025.00
Dec 31, 2025 2.00 Bn
Sep 30, 2025 -1.11 Mn
Jun 30, 2025 -1.07 Mn
Mar 31, 2025 -823,984.00
Dec 31, 2024 -840,273.00
Sep 30, 2024 -796,925.00
Jun 30, 2024 -750,760.00
Mar 31, 2024 -705,843.00
Dec 31, 2023 -661,232.00
Sep 30, 2023 -650,371.00
Jun 30, 2023 -632,941.00
Mar 31, 2023 -587,898.00
Dec 31, 2022 -544,830.00
Sep 30, 2022 -561,429.00
Jun 30, 2022 -641,653.00
Mar 31, 2022 -616,748.00
Dec 31, 2021 -469,062.00
Sep 30, 2021 -272,731.00
Jun 30, 2021 -86,452.00